Fast-scaling AI-powered biohacking and digital wellness subscription app delivering personalized habit optimization programs across four proven verticals: Anti-Alcohol, Anti-Vaping, Testosterone, and High Performance. Founded in 2019, the business generated approximately $10.4M in LTM net sales and reached $1.28M in MRR as of April 2026, with 88% of revenue coming from recurring subscriptions. The company has scaled rapidly while maintaining a relatively founder-light operating structure supported by a 26 full-time and 16 part-time in-house team.

Markets:

The business primarily serves consumers through direct-to-consumer web funnels and native iOS and Android apps. Its core markets span biohacking, digital wellness, habit optimization, and behavior-change programs, with established verticals focused on alcohol reduction, vaping cessation, testosterone optimization, and high performance. The platform is already localized in 10+ languages and has infrastructure covering the U.S., Europe, the UK, Canada, and LATAM, providing meaningful international expansion potential.

Marketing:

Customer acquisition is driven primarily by paid media, with Meta representing the dominant channel and Google significantly underdeveloped by comparison. The business has deployed approximately $8.8M on Meta and $80K on Google over the last 12 months. It also benefits from more than five years of pixel data, creative testing history, and funnel optimization. Organic channels including SEO, ASO, influencer marketing, and content remain largely untapped, despite a 4.34M+ email subscriber base and approximately 805K Instagram followers.

Products:

The platform offers a library of more than 150 personalized habits, AI-powered routines, biohacking tools, focus timers, binaural beats, and self-hypnosis sessions. Users are segmented into four core verticals based on onboarding quiz results and receive personalized programs through the mobile app. The business operates a 100% subscription-based B2C model with short-cycle introductory pricing across 1-week, 4-week, and 8-week plans that convert into recurring subscriptions.

Unit Economics:

Net CAC: ~$85
12M Net LTV: ~$112
12M Net ROAS: ~131%
Payback Period: ~4–4.5 months
Recurring Revenue: ~88%

The business has built a proven subscription and paid-acquisition engine, with recurring rebills serving as the primary revenue driver. Additional upside exists through improved lifecycle marketing, email monetization, organic acquisition, international expansion, and product enhancements designed to improve retention and customer lifetime value.

Financials:

LTM Net Sales: ~$10.4M
MRR: ~$1.28M as of April 2026
Recurring Revenue: ~88%
FY2025 Net Sales: ~$8.57M
FY2025 Net Income: ~$114K
FY2026 Forecast Gross Sales: ~$21.9M
FY2026 Forecast Net Income: ~$1.31M
FY2026 Forecast Net Margin: ~7.3%

The business scaled from approximately $2.5M in FY2024 gross sales to $10.4M in FY2025, representing approximately 4x year-over-year growth. The latest operating results and $1.28M MRR suggest the current run-rate is materially above historical levels, while forecast profitability is expected to improve as the business continues to scale.

Why was this business started?

The platform was founded in 2019 around AI-powered habit optimization and biohacking, targeting large consumer needs such as alcohol reduction, nicotine cessation, testosterone optimization, and performance improvement.

Website link, P&L and full deck will be shared privately with qualified buyers with committed capital.